Medical Devices Investors & VC Firms in North America
1074 firms in this list, with a median first check of $500K. 236 of them lead rounds. Generated from verified public data and updated continuously.
Gore Range Capital
SouthlakeSeries A–Late Stage$500K – $5M
3 people
Medvest Capital
Palm Beach GardensSeed–Series A$1M – $3M
3 people
Northtech Capital Investors
CambridgeSeed–Series A$25K – $200K
3 people
PBM Capital
CharlottesvilleSeries A–Late Stage
6 people
Origin Partners
HillsboroughSeed–Late Stage$3M – $5M
5 people
Excell Partners
RochesterPre-Seed–Series A$100K – $1.5M
3 people
Ballad Ventures
Johnson CityPre-Seed–Series B$500K – $1.5M
2 people
Soleus Capital
GreenwichLate Stage
2 people
Aberdare Ventures
San FranciscoSeed–Series A$500K – $15M
1 person
Cencora Ventures
San FranciscoSeed–Series B$1M – $10M
1 person
Ambit Health Ventures
BostonSeed–Series B
3 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
MaRS
TorontoPre-Seed–Growth
1 person
Rapha Capital Management, LLC
SurfsideSeed–Series A
1 person
Cancer Focus
HoustonPre-Seed–Seed
4 people
University Associates Venture Capital
TucsonSeed–Growth
4 people
Brace Pharma
AtlantaLate Stage
3 people
Early Stage Partners, LP
ClevelandSeed–Series A
3 people
Hunniwell Lake Ventures LLC
Palo AltoSeed–Series B
6 people
INP Capital
VancouverSeed–Late Stage
6 people
Redhills Ventures LLC
Las VegasSeed–Growth$125K – $7M
3 people
AYANA Capital LLC
TampaPre-Seed–Series A$1M – $3M
2 people
Buff Gold Ventures
BoulderPre-Seed–Series A
3 people
Granada Funds
ParamusSeed$150K – $400K
3 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.














































